Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Vascular Dysfunction After Preeclampsia
NCT06168461Phase 1Active, not recruiting
- Start
- Nov 2023
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in vascular dysfunction comparing placebo with aspirin (2 arms). Primary endpoints: Magnitude of microvascular endothelial function at 12 weeks, Magnitude of brachial artery endothelial function at 12 weeks and 1 more. Started Nov 2023; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
vascular dysfunction
Beyond the preview
Go deeper on NCT06168461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06168461.